Reattendances to the Children’s Emergency Department (CED) represent an important quality measure and may highlight areas for ...
A 4-month-old previously healthy, exclusively breast-fed male infant presented to the emergency department with severe ...
Background The use of biological response modifying drugs (BRMDs) in women of reproductive age is increasing, with reassuring ...
Correspondence to Dr Jamie Carter, Community Paediatric Dept, Seaside View CDC, Brighton General Hospital, Sussex Community NHS Foundation Trust, Brighton BN2 3EW, UK; Jamie.carter{at}nhs.net The way ...
England is close to losing its status as a low-endemic country for tuberculosis (TB).1 Scotland has seen a similar rise in TB prevalence and seems set to follow England unless urgent action is taken.2 ...
According to the Global Initiative to End Corporal Punishment (endcorporalpunishment.org), there are now 70 states worldwide with a full prohibition of corporal punishment of children. In 2007, ...
5 Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK Background Idiopathic intracranial hypertension (IIH) is a potentially disabling condition. There is a lack of evidence and ...
Objectives This study aimed to investigate the incidence of short stature at 3 years of age in a Japanese cohort of late preterm infants who were born at 34–36 weeks’ gestational age (GA). We compared ...
A randomised open label study of the combined use of paracetamol and ibuprofen to rapidly reduce fever is reported. The advantage of using both medications is less than half a degree centigrade in the ...
Background and objective Speech disorders are a common presenting concern to paediatricians. Yet evidence to guide detection and speech sound therapy referral of cases at risk for persistent speech ...
Correspondence to Professor Lorna K Fraser, Health Sciences, University of York, York YO10 5DD, UK; lorna.fraser{at}york.ac.uk Objective To assess trends in place of death for children with a ...
Objective Colchicine, derived from autumn crocus (Colchicum autumnale), has been used for centuries to treat arthritis. Currently, colchicine is licensed in the UK for the treatment of gout and ...